Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

4-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione

EU orphan designation number: EU/3/09/679
Active ingredient: 4-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione
Indication: Treatment of progressive supranuclear palsy
Sponsor: NOSCIRA, S.A.
Avda. De la Industria 52, E-28760 Tres Cantos (Madrid), Espaņa

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2009 Centralised Orphan - Designation EMEA/OD/074/09 (2009)8524 of 28/10/2009
21/11/2012 Centralised Orphan - Removal of orphan designation from Community Register